Logiscreen

Recursion Pharmaceuticals Inc - Class A

$3.31
Market Cap 1.75B
ROE -54.3%
Gross Margin -93.0%
Debt/Equity 0.1
Current Ratio 5.5
Revenue QoQ -56.1%
EPS QoQ -0.6%
F-Score 3

About

Recursion Pharmaceuticals Inc - Class A

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-3.58
vs median 33.61
P/B
1.96
vs median 2.16
ROE
-0.54
vs median 0.09

Lower quality - review fundamentals carefully

Mid-cap company with growth potential

Similar companies

CLDXPHVSMLYSTRILZLABOCUL
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics